Journal article

High rates of multidrug-resistant and rifampicin-resistant tuberculosis among re-treatment cases: where do they come from?

Romain Ragonnet, James M Trauer, Justin T Denholm, Ben J Marais, Emma S McBryde

BMC Infectious Diseases | BIOMED CENTRAL LTD | Published : 2017

DOI: 10.1186/s12879-016-2171-1

Download PDF

Citation metrics

28Web of Science
24Scopus
28Dimensions

Keywords

Tuberculosis
Inappropriate Therapy
Antitubercular Agents
Burden
Area
Rifampin
Tuberculosis, Multidrug-Resistant
Infectious Diseases
Misdiagnosis
Drug Resistance Amplification
Short-Course Dots
World Health Organization
Re-Treatment
Mycobacterium-Tuberculosis
Life Sciences & Biomedicine
Humans
Epidemics
Retreatment
Risk
Tuberculosis, Pulmonary
Transmission
Science & Technology
Models, Statistical
Causal Pathway
Multidrug-Resistant Tuberculosis
Drug-Resistance
South-Africa
Reinfection